XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.21.2

STOCK OPTIONS AND WARRANTS | 12 Months Ended
--- | ---
Sep. 30, 2021
STOCK OPTIONS AND WARRANTS |
STOCK OPTIONS AND WARRANTS | NOTE I – STOCK OPTIONS AND WARRANTS Warrants Transactions involving warrants (see Note H) are summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted Average
​ | ​ | Number of | ​ | Exercise Price Per
​ |  | Shares |  | Share
Balance at October 1, 2020 |  | 1,038,919 | ​ | $ | 10.83
Granted |  | 259,000 | ​ |  | 7.14
Exercised |  | (520,151) | ​ |  | (5.25)
Cancelled or expired |  | (32,500) | ​ |  | (171.56)
Balance, September 30, 2021 |  | 745,268 | ​ | $ | 6.44
​ Stock Options During June 2020, the Board of Directors and subsequently during September 2020, the holders of a majority of the outstanding shares of common stock approved the 2020 Equity Incentive Plan (the “2020 Incentive Plan”). The 2020 Incentive Plan, among other things, reserves an additional 3,500,000 shares of the Company’s common stock for issuance in the form of equity-based awards to employees, directors, consultants, and other service providers, and those of the Company’s affiliates. The maximum total grant date fair value of awards granted under the 2020 Incentive Plan to individuals in their capacity as non-employee directors may not exceed $250,000 in any single calendar year. The 2020 Incentive Plan’s expiration date is September 15, 2030. NOTE I – STOCK OPTIONS AND WARRANTS, continued Stock Options, continued The 2020 Incentive Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to the Company's success with an award of options to purchase shares of common stock. As of September 30, 2021, a total of 6,894 shares have been issued and options to purchase 501,240 shares have been granted under the Company’s Incentive Plans. In 2005, the Board of Directors and the holders of a majority of the outstanding shares of common stock approved the 2005 Incentive Stock Plan, as amended and restated as of January 21, 2015 (the “2005 Incentive Plan”, collectively with the 2020 Incentive Plan, the “Company’s Incentive Plans”). Effective as of September 16, 2020, no further awards will be made under the Company’s 2005 Incentive Stock Plan, as amended and restated. Transactions involving stock options issued are summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Weighted Average | ​ | Aggregate | ​ | Average
​ | ​ | Number of | ​ | Exercise Price Per | ​ | Intrinsic | ​ | Contractual
​ |  | Shares |  | Share |  | Value |  | Life (years)
Outstanding at October 1, 2020 |  | 320,990 | ​ | $ | 57.75 |  |  |  |
Granted |  | 203,405 | ​ |  | 6.15 |  |  |  |
Exercised |  | 30,955 | ​ | ​ | 4.39 |  |  |  |
Cancelled or expired |  | 6,063 | ​ | ​ | 5.01 |  |  |  |
Outstanding at September 30, 2021 |  | 487,377 | ​ | ​ | 40.26 |  |  |  |
Vested at September 30, 2021 |  | 478,627 | ​ | ​ | 40.90 | ​ | — |  | 7.54
Non-vested at September 30, 2021 |  | 8,750 | ​ | ​ | 5.46 | ​ | — | ​ | 8.71
​ For the fiscal year ended September 30, 2021, the Company issued an aggregate of 203,405 options to employees and non-employee board of director members and consultants. For the fiscal year ended September 30, 2020, the Company issued an aggregate of 155,395 options to employees and non-employee board of director members and consultants. During November 2021, the Company granted 361,552 options to officers of the Company. These options have a ten year term and vested immediately. Also during November 2021, the Company granted 213,889 options to non-employee board of director members. The options granted to the non-employee board of directors have a ten year term and vest on the one-year anniversary of the date of grant. The fair value of options granted during the fiscal years ended September 30, 2021 and 2020 was determined using the Black Scholes Option Pricing Model. For the purposes of the valuation model, the Company used the simplified method for determining the granted options expected lives. The simplified method is used since the Company does not have adequate historical data to utilize in calculating the expected term of options. The fair value for options granted was calculated using the following weighted average assumptions: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2021 |  | 2020 |
Stock price | ​ | $ | 6.43 | ​ | $ | 8.40 | ​
Exercise price | ​ | $ | 6.43 | ​ | $ | 8.45 | ​
Expected term | ​ | ​ | 5.10 | ​ |  | 6.85 | ​
Dividend yield | ​ |  | — | ​ |  | — | ​
Volatility | ​ |  | 141 | % |  | 136 | %
Risk free rate | ​ |  | 0.47 | % |  | 0.86 | %
​ NOTE I – STOCK OPTIONS AND WARRANTS, continued Stock Options, continued The Company recorded $1,668,003 and $1,001,082 as stock compensation expense within selling, general and administrative for fiscal years ended September 30, 2021 and 2020, respectively. As of September 30, 2021, unrecorded compensation cost related to non-vested awards was $20,485 which is expected to be recognized over a weighted average period of approximately 2.6 years. The weighted average grant date fair value per share for options granted during the fiscal years ended September 30, 2021 and 2020 was $5.72 and $7.49, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration